Asaleo Care Limited, together with its subsidiaries, manufactures, markets, distributes, and sells hygiene, personal care, and consumer tissue products in Australia, New Zealand, Fiji, and the Pacific Islands. The company operates in Retail and Business to Business segments. It offers toilet and facial tissues, and flushable wipes under the Sorbent brand; paper towels under the Handee Ultra brand; feminine hygiene products under the Libra brand; incontinence products under the TENA brand; workplace hygiene products under the Tork brand; toilet papers under the Purex brand; hygiene products under the Orchid brand; and toilet tissues under the Viti brand. The company sells its products through a distributor network to business end users, including schools, restaurants, shopping centers, airports, industrial companies, aged care facilities, and hospitals, as well as retail customers. The company was formerly known as PEPSCA Limited and changed its name to Asaleo Care Limited in May 2014. Asaleo Care Limited was founded in 1932 and is based in Springvale, Australia. As of June 10, 2021, Asaleo Care Limited operates as a subsidiary of Essity Group Holding BV.
Research context
Asaleo Care Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Asaleo Care Limited is currently in a long term uptrend where the price is trading 10.0% above its 200 day moving average.
From a valuation standpoint, the stock is 73.5% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 1.8.
Asaleo Care Limited's total revenue sank by 6.4% to $205M since the same quarter in the previous year.
Its net income has dropped by 9.1% to $13M since the same quarter in the previous year.
Finally, its free cash flow grew by 502.5% to $67M since the same quarter in the previous year.
Based on the above factors, Asaleo Care Limited gets an overall score of 3/5.